1 - 5 of 5 Results Clear All
The new immune networks have implications for developing immunotherapies and understanding autoimmune diseases
News Release Research (Publication) Autoimmune Diseases Genomic Immunology Marson Lab
New York Times—The microbiome plays a role in many autoimmune conditions, and some scientists believe that fecal transplants from individuals living in non-industrialized cultures may provide a solution. Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, explains why it may not be that easy.
Gladstone Experts Autoimmune Diseases Data Science and Biotechnology Pollard Lab Microbiome
Clinical Omics—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains his lab's recent discovery of the the gene networks that distinguish regulatory T cells from other types of T cells, and the implication for therapies against cancer and autoimmune diseases.
Gladstone Experts Autoimmune Diseases Marson Lab
Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab's recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.
Gladstone Experts Autoimmune Diseases Genomic Immunology Marson Lab
Live Science—Senior Investigator Warner Greene, MD, PhD, lends his expertise in immunology to a detailed article describing the various types of antibodies the immune system produces during an infection, and how they help fight invaders or can be used as therapies.
Gladstone Experts COVID-19 Autoimmune Diseases Center for HIV Cure Research Greene Lab
